Medtech
Featured Experts
Jake Henry
Senior PartnerChicago
Leads McKinsey’s global work on mergers, acquisitions, separations, divestitures and JV’s/alliances. Serves leading medical technology and biopharma/biotech companies in setting strategy, pursuing growth opportunities, and achieving operational excellence.
Robert Linden
Senior PartnerBay Area
Global leader of our Medical Products Practice, advising a broad range of healthcare clients – from early-stage innovators to global, diversified players – on growth, commercial strategy, R&D, performance improvement, and operations excellence
Christian Zerbi
PartnerLondon
Leads McKinsey’s medtech work across Europe and serves medical-device clients on strategy, commercial excellence, and transformation topics
Featured Insights
Medtech Pulse: Thriving in the next decade
-
Medtech leaders are devising strategies to catch the next wave of value creation amid uncertain macroeconomics and evolving industry trends.
Rewired pharma companies will win in the digital age
-
Despite progress, most pharma companies have not fully rewired their tech, tools, and operating models to realize their digital and analytics ambitions. Five actions can help them achieve scale.
Delivering a stellar experience for all key stakeholders in medtech
-
With the focus on CX gaining momentum in medtech, companies can look to more mature industries to develop a stellar experience that boosts stakeholder satisfaction and business returns.
Life sciences technology insights: Scaling a product and platform model
-
Most life sciences companies are experimenting with product and platform models that speed delivery of user-focused technology but struggle to truly scale. Six actions can accelerate the transition.